Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q1 FY2020 Earnings Presentation
12 slides from Narayana Hrudayalaya's earnings presentation, August 2019
Slide 1: Investor Presentation
Investor Presentation August 2019
Slide 2: Important Disclosure
Important Disclosure No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its da
Slide 3: NH at a Glance
NH at a Glance As on 30th June 2019 NH’s footprint in India 50 Healthcare Facilities Operational beds 21 Owned / Operated Hospitals(1) 5,294 Beds Kakriyal, Jammu Northern Region 2 Managed Hospitals(2) 498 Beds 3 hospitals Operational beds: 614 7 Heart Centres 371 Beds 19 Primary Healthcare Facilitie
Slide 4: Key Highlights – Q1 FY20
Key Highlights – Q1 FY20 ▪ Narayana Institute of Cardiac Sciences, Bengaluru successfully performed the world’s first Patent Ductus Arteriosus (PDA) stenting and southern region’s first thoracopagus surgery on a conjoined-twin with a single heart ▪ In a rare case, a 70-year-old patient suffering fro
Slide 5: Revenue Mix – India Business (Q1 FY20)
Revenue Mix – India Business (Q1 FY20) Operating Revenues Business Mix INR mn 6,685 95% 4% 5,771 1% (1) Owned / Operated Hospitals Heart Centres Q1 FY19 Q1 FY20 Other Anciliary Businesses (2) Speciality-Profile(6,7) Payee-Profile(3) Cluster-Wise(5) 12% 11% 7% 5% 15% 17% 40% 9% 43% 5% 51% 9% 21% 27%
Slide 6: Operational Review – India Business
Operational Review – India Business Operational Beds(1) Discharges(2) 66,535 55,382 6,037 6,173 30th June 2018 30th June 2019 Q1 FY19 Q1 FY20 ARPOB(2) ALOS(2) INR mn Days 9.7 8.6 4.2 3.6 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 (1) Includes Managed Hospitals (2) Excludes Managed Hospitals 6
Slide 7: Operational Review – HCCI
Operational Review – HCCI ARPOB Discharges(1) US$ mn 1.8 615 660 1.5 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 Operating Revenues Profitability US$ mn US$ mn EBITDA EBITDA Margin (%) 22.3% 15.6 11.2 6.6% 3.5 0.0 0.7 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 (1) ALOS for the period Q1 FY19 was 4.4 days and 4.9 days for
Slide 8: Regional Split – India Business (Q1 FY20)
Regional Split – India Business (Q1 FY20) This considers owned/operated hospitals in India (excl. Jammu) Southern Eastern Regions Bangalore Kolkata Western Delhi NCR Peripheral Peripheral % of Hospital Operating 40% 6% 27% 5% 15% 7% Revenues YoY Revenue Growth 14% 3% 10% 28% 11% 26% 57% % of Hospita
Slide 9: Maturity Profile – India Business (Q1 FY20)
Maturity Profile – India Business (Q1 FY20) This considers owned/operated hospitals in India (excl. Jammu) Maturity Hospitals (Exc. Hospital % of Hospital Key Performance Indicators(1) Managed Hospitals & Operating Revenues(1) Operational Beds(1) Jammu)(1) % of Total YoY Growth ARPOB (INR mn) Discha
Slide 10: Profitability Snapshot
Profitability Snapshot – India Business EBITDA and EBITDA Margin Cost Structure INR mn Movement across 3 New Hospitals % of Operating Revenues Q1 FY19 Q1 FY20 Losses Revenues Losses Revenues 92.8% Rental / Revenue Share 88.2% Total 196 366 Total 167 574 24.0% 2.6% 1.5%(2) 21.0% 44.1% Doctors’ Cost 4
Slide 11: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR mn, unless stated otherwise Profit and Loss Statement(1,3) Key Balance Sheet Items(1,4) Particulars (INR mn) Q1 FY19 Q1 FY20 Particulars 30th June 2019 Total Operating Revenue 6,523 7,774 Shareholder Equity 10,879 Purchase of Medical Consumables, Dru
Slide 12: Shareholding Pattern
Shareholding Pattern Shareholding as on 30th June 2019(1) Total Number of Shares 204,360,804 ESOP Trust Others 0.8% 3.3% PE Investors 13.1%(3) CDC - 7.9% Asia Growth Capital - 5.2% FIIs / DIIs and Retail 19.0% Promoter Group FIIs - 10.6% 63.9%(2) DIIs - 4.8% Retail/Others - 3.7% (1) Percentages migh
Narayana Hrudayalaya — Q1 FY2020 Earnings Presentation on 6ix